Harout Semerjian
CIK 1809747 · President and CEO · last filed 2025-08-08
Harout Semerjian is a President and CEO who has filed 6 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing, for GERN, was dated Aug 8, 2025. Across all open-market trades the lifetime net is +$32.2K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
6
$32.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GERN | President and CEO | — | $1.15 | — | $0 | 1 | 2025-08-08 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Chief Executive Officer | 25,000 | $15.70 | $392.5K | $32.2K | 4 | 2024-01-17 |
| IMMUNOMEDICS INC (IMMU) Delisted | President and CEO | 50,075 | — | — | $0 | 1 | 2020-04-20 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-08 | GERN | Grant (A) | — | $0 | EDGAR |
| 2024-01-17 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-20 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-14 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Buy (P) | +25,000 | $32.2K | EDGAR |
| 2022-01-25 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-20 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | +50,075 | $0 | EDGAR |